Stabilized interferon compositions
US7662369B2 · kind B2 · utility
2Cited by
26References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2005 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Jan 27, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/42
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Stabilized pharmaceutical formulations comprising IFN-β and highly purified mannitol are provided. The highly purified mannitol stabilizes the compositions by reducing the formation of IFN-β adducts in comparison with IFN-β formulated with mannitol that has not been highly purified. Methods for increasing the stability of IFN-β or a variant thereof in a liquid or lyophilized composition and for increasing storage stability of such a composition are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.